Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
Wei Ding(Mayo Clinic), Neil E. Kay(Mayo Clinic), Justin C. Boysen, Susan M. Schwager(Mayo Clinic in Arizona), Wenting Wu(East China Normal University), Renee C. Tschumper, Traci R. Knox, Diane F. Jelinek(Mayo Clinic in Arizona)
Cited by 148
Related Papers
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2019|735
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
|Journal of Clinical Oncology|2021|630
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
|Neuro-Oncology|2008|387
Drivers, trends, and potential impacts of long-term coastal reclamation in China from 1985 to 2010
|Estuarine Coastal and Shelf Science|2016|333